Peter Werner
Impact in
- Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms
- Parkinson's Disease Mechanisms and Treatments
- Developmental Neuroscience top 1%
- Neurogenesis and neuroplasticity mechanisms
Papers in
-
- Neuroinflammation and Neurodegeneration Mechanisms 7
- Parkinson's Disease Mechanisms and Treatments 6
-
- Neuroscience and Neuropharmacology Research 9
- Co-authors
- Cedric S. Raine (2 shared papers)David Pitt (2 shared papers)C. Warren Olanow (2 shared papers)Paul F. Good (1 shared paper)Daniel P. Perl (1 shared paper)Amy P. Hsu (1 shared paper)Elimor Brand‐Schieber (5 shared papers)Diana Casper (5 shared papers)
- Journals
- Neurology (3 papers)European Journal of Nuclear Medicine and Molecular Imaging (3 papers)Journal of Nuclear Medicine (2 papers)FEBS Letters (2 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)
- Partner nations
- United StatesGermanyHungary
In The Last Decade
Peter Werner
44 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 109
- Neurology 769
- Developmental Neuroscience 362
- Neurology 688
- Cellular and Molecular Neuroscience 856
- Biological Psychiatry 104
Countries citing papers authored by Peter Werner
This map shows the geographic impact of Peter Werner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Werner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Werner more than expected).
Fields of papers citing papers by Peter Werner
This network shows the impact of papers produced by Peter Werner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Werner. The network helps show where Peter Werner may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Werner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 760 | |
| 2 | 1998 | 484 | |
| 3 | 2001 | 418 | |
| 4 | 1995 | 200 | |
| 5 | 1998 | 161 | |
| 6 | 2000 | 114 | |
| 7 | 2013 | 112 | |
| 8 | 2005 | 110 | |
| 9 | 1997 | 89 | |
| 10 | 2017 | 84 | |
| 11 | 2007 | 75 | |
| 12 | 1998 | 73 | |
| 13 | 2004 | 61 | |
| 14 | 2005 | 51 | |
| 15 | 2015 | 51 | |
| 16 | 2008 | 48 | |
| 17 | 2000 | 47 | |
| 18 | 2007 | 45 | |
| 19 | 2003 | 45 | |
| 20 | 2004 | 42 |
About Peter Werner
Peter Werner is a scholar working on Neurology, Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging, Physiology and Neurology, having authored 45 papers that have together received 3.4k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Medical Imaging Techniques and Applications (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers), Inflammatory mediators and NSAID effects (4 papers), Advanced MRI Techniques and Applications (4 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Multiple Sclerosis Research Studies (3 papers). The work is most often cited by research in Neurology (769 citations), Developmental Neuroscience (362 citations), Neurology (688 citations), Cellular and Molecular Neuroscience (856 citations) and Biological Psychiatry (104 citations). Peter Werner has collaborated with scholars based in United States, Germany and Hungary. Frequent co-authors include Cedric S. Raine, David Pitt, C. Warren Olanow, Paul F. Good, Daniel P. Perl, Amy P. Hsu, Elimor Brand‐Schieber, Diana Casper, Emilce Carrasco and Michael Schütte. Their work appears in journals such as Neurology, European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine, FEBS Letters and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.